Then you will be able to mark statistics as favourites and use personal statistics alerts. Save statistic in. XLS format. PNG format.
PDF format. Show details about this statistic. Exclusive Premium functionality. Register in seconds and access exclusive features. Full access: To this and over 1 million additional datasets Save Time: Downloads allow integration with your project Valid data: Access to all sources and background information. Exclusive Corporate feature.
Corporate Account. Statista Accounts: Access All Statistics. Basic Account. The ideal entry-level account for individual users. Corporate solution including all features. It also houses 90 universities and colleges, offering talents for over 1, life science companies. The city is the center for institutions that focus on cell and gene therapy, an innovative technology that shows promise in treating many diseases. In , Greater Philadelphia was home to about 36 cell and gene therapy companies, with a gene therapy workforce of 4, that could increase to 11, in a decade.
Maryland, particularly the BioHealth Capital Region, is home to world-renowned research institutions and universities, groups pioneering new health strategies, and world-leading infectious disease research and vaccine development.
It is also the fastest-growing region for healthcare companies in the US and ranked top 1 in the nation for science and engineering talent. Finding a biotech job in Maryland will not only help you land a high-paying job, but it is also a ground for research and learning innovative skills that can make you competent and skilled.
Other cities that are ideal locations to find biotech jobs are New York and New Jersey. New York is the largest city in the United States, with an extensive health system employing 14, life science professionals. It calls for 16, new life sciences jobs and about 3 million square feet of new life science space. These cities are trending locations to job hunt for life science professionals looking for high-paying jobs and a learning experience.
Considering each city's funding and qualities, it's up to you to choose where you want to work. You may consider other factors like living expenses, distance from home, and the likelihood for promotions, training, and benefits. Timing is critical: biotechs need to make careful judgments about when they should go to financial markets.
Some of the experts we spoke with warned against rushing to the United States for funding too early, since later rounds of investment or an IPO might be more appropriate. Investors looking for strong returns are more likely to back companies with experience, so European biotechs need to attract sufficient entrepreneurial and biotech talent, build credibility, and seek exposure to and explore networks outside Europe. Teams must plan ambitiously, execute well, and forge strong relationships with the right stakeholders.
Given the shortage of experienced talent, biotechs must also be flexible about remote working and comfortable with virtual teams to secure the right people—from beyond Europe as well as within it. Nasdaq is the biggest source of public funding, so European biotechs with global aspirations will want to make it a part of their strategy to raise the investment they need to compete. To build global credibility, companies will also need to create a board and local networks geared to larger private rounds and a potential IPO.
And as European biotechs seek investment, they should also look east as well as west, patiently building a presence in China to understand an unfamiliar investor landscape, raise capital, and form partnerships that will enable them to thrive and grow Exhibit 6.
European biotechs offer investors space for growth and momentum. With a strong science base that is less fully utilized than its US counterpart, they have ample opportunities to translate innovation into products. Armed with adequate funding to expand, they could achieve global competitiveness and success in coming years.
Never miss an insight. We'll email you when new articles are published on this topic. Accept Use minimal essential cookies. Skip to main content.
Biotech in Europe: A strong foundation for growth and innovation. We strive to provide individuals with disabilities equal access to our website. If you would like information about this content we will be happy to work with you. Explore a career with us Search Openings.
Seattle ranks highest when it comes to patents and 8th in terms of NIH funding and VC funding, but 10th for jobs. Philadelphia, Pennsylvania has the 5th highest population of all cities in the United States. The Greater Philadelphia area ranks 6th in terms of venture capital and NIH funding as well as lab space and jobs. The area ranks 7th in terms of patents.
It is home to the second most biotechnology, medical device, and pharmaceutical companies of all major groups. This region is 3rd in NIH funding as well as patents but 4th in terms of lab space and 9th in terms of jobs. Maryland is home to John Hopkins University, one of the most prestigious and respected hospitals in the country. All of these institutions rank highly in the biotechnology and life science industries. Washington, D. New York City is the largest city in the United States.
0コメント